| Literature DB >> 33519826 |
Sara Ciullini Mannurita1, Rayan Goda2, Ebe Schiavo2, Maria Luisa Coniglio1, Annachiara Azzali1, Ilaria Fotzi1, Annalisa Tondo1, Veronica Tintori1, Stefano Frenos1, Maria Chiara Sanvito1, Marina Vignoli1, Cristina Luceri2, Elisabetta Bigagli2, Alessia Grassi3, Mario Milco D'Elios3, Claudio Favre1, Eleonora Gambineri1,2.
Abstract
STAT3 gain-of-function (GOF) mutations can be responsible for an incomplete phenotype mainly characterized by hematological autoimmunity, even in the absence of other organ autoimmunity, growth impairment, or severe infections. We hereby report a case with an incomplete form of STAT3 GOF intensified by a concomitant hereditary hematological disease, which misleads the diagnosis. The patient presented with lymphadenopathy, splenomegaly, hypogammaglobulinemia, and severe autoimmune hemolytic anemia (AIHA) with critical complications, including stroke. A Primary Immune Regulatory Disorders (PIRD) was suspected, and molecular analysis revealed a de novo STAT3 gain-of-function mutation. The response to multiple immune suppressive treatments was ineffective, and further investigations revealed a spectrin deficiency. Ultimately, hematopoietic stem cell transplantation from a matched unrelated donor was able to cure the patient. Our case shows an atypical presentation of STAT3 GOF associated with hereditary spherocytosis, and how achievement of a good long-term outcome depends on a strict clinical and laboratory monitoring, as well as on prompt therapeutic intervention.Entities:
Keywords: STAT3 gain-of-function; autoimmune lymphoproliferative syndrome; hematopoietic stem cell transplantation; hemolytic anemia; hereditary spherocytosis; lymphadenopathy; primary immune regulatory disorders; spectrin deficiency
Mesh:
Substances:
Year: 2021 PMID: 33519826 PMCID: PMC7843414 DOI: 10.3389/fimmu.2020.620046
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561